Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALK alteration is a frequent event in aggressive breast cancers.

Breast cancer research : BCR - 17 Sept 2015

Siraj Abdul K, Beg Shaham, Jehan Zeenath, Prabhakaran Sarita, Ahmed Maqbool, R Hussain Azhar, Al-Dayel Fouad, Tulbah Asma, Ajarim Dahish, Al-Kuraya Khawla S

Abstract excerpt

INTRODUCTION: Breast cancer is the most common female malignancy worldwide and, despite improvements in treatment modalities, there are increased chances of recurrence and metastasis in a substantial number of cases and it remains one of the major causes of mortality among female cancer patients. Anaplastic lymphoma kinase (ALK) gene has been found to be altered in several solid and hematologic tumors. We aimed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Immunohistochemistry

Share to In Situ Hybridization, Fluorescence

Share to Ki-67 Antigen

Share to Neoplasm Recurrence, Local

Share to Receptor Protein-Tyrosine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 26384210
DOI: 10.1186/s13058-015-0610-3
PMCID: PMC4588266

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALK alteration is a frequent event in aggressive breast cancers.PMID 26384210Read ↗

ALK protein expression and gene copy number alterations in triple-negative breast cancer: Clinical implications.Semantic proximity Read ↗

ALK gene alterations in cancer: biological aspects and therapeutic implications.Semantic proximity Read ↗

Targeting oncogenic ALK: a promising strategy for cancer treatment.Semantic proximity Read ↗

ALK Gene Amplified in Most Inflammatory Breast CancersSemantic proximity Read ↗

An Anaplastic Lymphoma Kinase Pathway Signature is associated with Cell De-differentiation, Neoadjuvant Response and Recurrence Risk in Breast CancerSemantic proximity Read ↗

Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many FacesSemantic proximity Read ↗

The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic DatasetsSemantic proximity Read ↗

Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity.Semantic proximity Read ↗

Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer.Semantic proximity Read ↗

A new look at the ALK gene in cancer: copy number gain and amplificationSemantic proximity Read ↗

Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.Semantic proximity Read ↗

Integrated analysis of the clinical consequence and associated gene expression of ALK in ALK-positive human cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.